SECTION 2. HAZARDS IDENTIFICATION

Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
Acute toxicity, Oral
(Category 4), H302
Acute toxicity, Dermal
(Category 4), H312
Skin irritation
(Category 2), H315
Eye irritation
(Category 2A), H319
Specific target organ toxicity -single exposure
(Category 3), Respiratory system, H335

GHS Label elements, including precautionary statements
Pictogram

Signal word
Warning
Hazard statement(s)
H302 + H312
Harmful if swallowed or in contact with skin
H315
Causes skin irritation.
H319
Causes serious eye irritation.
H335
May cause respiratory irritation.
Precautionary statement(s)
P261
Avoid breathing dust/ fume/ gas/ mist/ Vapors/ spray.
P264
Wash skin thoroughly after handling.
P270
Do not eat, drink or smoke when using this product.
P271
Use only outdoors or in a well-ventilated area.
P280
Wear protective gloves/ eye protection/ face protection.
P301 + P312
IF SWALLOWED: Call a POISON CENTER or doctor/ physician if you feel unwell.
P302 + P352
IF ON SKIN: Wash with plenty of soap and water.
P304 + P340
IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P312
Call a POISON CENTER or doctor/ physician if you feel unwell.
P322
Specific measures (see supplemental first aid instructions on this label).
P330
Rinse mouth.
P332 + P313
If skin irritation occurs: Get medical advice/ attention.
P337 + P313
If eye irritation persists: Get medical advice/ attention.
P362
Take off contaminated clothing and wash before reuse.
P403 + P233
Store in a well-ventilated place. Keep container tightly closed.
P405
Store locked up.
P501
Dispose of contents/ container to an approved waste disposal plant.
Hazards not otherwise classified (HNOC) or not covered by GHS-none

SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS

Substances
Synonyms: BPSCCO 2223
CAS-No.: 116739-98-1
Hazardous components
Component
Classification
Concentration
Bismuth lead strontium calcium copper oxide
Acute Tox.
4; Skin Irrit.
2; Eye Irrit.
2A; STOT SE 3; H302 + H312, H315, H319, H335 -

SECTION 4. FIRST AID MEASURES

Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
Move out of dangerous area.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2) and/or in section 11
Indication of any immediate medical attention and special treatment needed
no data available

SECTION 5. FIREFIGHTING MEASURES

Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Nature of decomposition products not known.
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

SECTION 6. ACCIDENTAL RELEASE MEASURES

Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing Vapors, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

SECTION 7. HANDLING AND STORAGE

Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire protection.
For precautions see section 2.
Conditions for safe storage, including any incompatibilities
Keep container tightly closed in a dry and well-ventilated place.
Moisture sensitive.
Store under inert gas.
Keep in a dry place.
Specific end use(s)
Apart from the uses mentioned in section 1 no other specific uses are stipulated.

SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION

Control parameters
Components with workplace control parameters
Contains no substances with occupational exposure limit values.
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES

Information on basic physical and chemical properties
Appearance
Form: powder
Color: black
Odor: no data available
Odor Threshold: no data available
pH: no data available
Melting point/freezing point: no data available
Initial boiling point and boiling range: no data available
Flash point: not applicable
Evaporation rate: no data available
Flammability (solid, gas): no data available
Upper/lower flammability or explosive limits: no data available
Vapor pressure: no data available
Vapor density: no data available
Relative density: no data available
Water solubility: no data available
Partition coefficient: n-octanol/water: no data available
Auto-ignition temperature: no data available
Decomposition temperature: no data available
Viscosity: no data available
Explosive properties: no data available
Oxidizing properties: no data available
Other safety information: no data available

SECTION 10. STABILITY AND REACTIVITY

Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Water
Hazardous decomposition products
Other decomposition products-no data available
In the event of fire: see section 5.

SECTION 11. TOXICOLOGICAL INFORMATION

Information on toxicological effects
Acute toxicity
no data available
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.
ACGIH: No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential carcinogen by ACGIH.
NTP: No component of this product present at levels greater than or equal to 0.1% is identified as a known or anticipated carcinogen by NTP.
OSHA: No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential carcinogen by OSHA.
Reproductive toxicity
no data available
no data available
Specific target organ toxicity -single exposure
Inhalation-May cause respiratory irritation.
Specific target organ toxicity -repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
Lead salts have been reported to cross the placenta and to induce embryo-and feto-mortality. They also have teratogenic effect in some animal species. No teratogenic effects have been reported with exposure to organometallic lead compounds. Adverse effects of lead on human reproduction, embryonic and fetal development, and postnatal (e.g., mental) development have been reported. Excessive exposure can affect blood, nervous, and digestive systems. The synthesis of hemoglobin is inhibited and results in anemia. If left untreated, neuromuscular dysfunction, possible paralysis, and encephalopathy can result. Additional symptoms of overexposure include: joint and muscle pain, weakness of the extensor muscles (frequently the hand and wrist), headache, dizziness, abdominal pain, diarrhea, constipation, nausea, vomiting, blue line on the gums, insomnia, and metallic taste. High body levels produce increased cerebrospinal pressure, brain damage, and stupor leading to coma and often death., Symptoms of chronic bismuth toxicity in humans consists of decreased appetite, weakness, rheumatic pain, diarrhea, fever, metal line on the gums, foul breathe, gingivitis, and dermatitis. Jaundice and conjunctival hemorrhage are rare, but have been reported. Bismuth nephropathy with proteinuria may occur. The kidney is the site of highest concentration with the liver being considerably lower. Bismuth does pass into the amniotic fluid and into the fetus., Symptoms of systemic copper poisoning may include: capillary damage, headache, cold sweat, weak pulse, and kidney and liver damage, central nervous system excitation followed by depression, jaundice, convulsions, paralysis, and coma. Death may occur from shock or renal failure. Chronic copper poisoning is typified by hepatic cirrhosis, brain damage and demyelination, kidney defects, and copper deposition in the cornea as exemplified by humans with Wilson's disease. It has also been reported that copper poisoning has lead to hemolytic anemia and accelerates arteriosclerosis., To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.

SECTION 12. ECOLOGICAL INFORMATION

Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

SECTION 13. DISPOSAL CONSIDERATIONS

Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contact a licensed professional waste disposal service to dispose of this material.
Contaminated packaging
Dispose of as unused product.

SECTION 14. TRANSPORT INFORMATION

DOT (US)
Not dangerous goods
IMDG
Not dangerous goods
IATA
Not dangerous goods

SECTION 15. REGULATORY INFORMATION

SARA 302 Components
SARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title III Section 302.
SARA 313 Components
SARA 313: This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313.
SARA 311/312 Hazards
Acute Health Hazard
Massachusetts Right To Know Components
No components are subject to the Massachusetts Right to Know Act.
Pennsylvania Right To Know Components
Bismuth lead strontium calcium copper oxide
CAS-No. 116739-98-1
Revision Date
New Jersey Right To Know Components
Bismuth lead strontium calcium copper oxide
CAS-No. 116739-98-1
Revision Date
California Prop. 65
Components
This product does not contain any chemicals known to State of California to cause cancer, birth defects, or any other reproductive harm.